Cardiovascular disease is a leading cause of morbidity and mortality in patients who have undergone solid organ transplantation. Despite this, limited evidence exists for how to appropriately identify and mitigate cardiovascular risk in this population. In this blog, we discuss the management of dyslipidemia in transplant recipients.
The long-awaited American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines were recently released at AHA 2018 in Chicago. This update can be described as an amalgamation of various previous guidelines and highlights the growing complexity of lipid management. In this post, we highlight some of the most important changes in the latest update.